WeVote

Bill

Bill

SB 2224

Uniform Controlled Substances Act; add certain substances to Schedule IV.

2025 Regular Session Introduced by Angela Hill

Mississippi bill to reclassify unspecified controlled substances to Schedule IV, increasing penalties and restrictions on lower-abuse-potential drugs, died in committee.

Died In Committee
0
WeVote Research Nonpartisan
Bill Summary · SB 2224

Legislative bill overview

SB 2224 proposes to add certain controlled substances to Schedule IV under Mississippi's version of the Uniform Controlled Substances Act. Schedule IV classification represents substances with lower abuse potential than Schedule I-III drugs but still subject to regulation and criminal penalties. The bill did not advance past the Drug Policy Committee before dying in committee on February 4, 2025.

Why is this important

Schedule IV classification affects criminal penalties for possession and distribution, pharmaceutical availability through prescription, and research restrictions. The designation signals the state legislature's assessment of a substance's danger and medical utility, influencing law enforcement priorities and public health policy. This type of scheduling is typically responsive to emerging drug trends or scientific evidence about substance risk.

Potential points of contention

  • Lack of public specificity: The bill text does not specify which substances would be added, making it difficult to assess whether the classifications are scientifically justified or address genuine public health concerns
  • Enforcement burden: Adding substances to Schedule IV expands law enforcement responsibilities and criminal justice system costs without clear detail on implementation
  • Medical access trade-offs: Schedule IV status restricts legitimate medical and research uses while criminal penalties may not effectively deter problematic use of lower-abuse-potential substances

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.